Cargando…

Analysis of Vaccine Effectiveness Against COVID-19 and the Emergence of Delta and Other Variants of Concern in Utah

This cross-sectional study analyzes the effectiveness of COVID-19 vaccines against Delta and other variants in Utah.

Detalles Bibliográficos
Autores principales:	Keegan, Lindsay T., Truelove, Shaun, Lessler, Justin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703247/ https://www.ncbi.nlm.nih.gov/pubmed/34940869 http://dx.doi.org/10.1001/jamanetworkopen.2021.40906

Ejemplares similares

A scenario modeling pipeline for COVID-19 emergency planning
por: Lemaitre, Joseph C., et al.
Publicado: (2021)

The efficacy of COVID-19 vaccines against the B.1.617.2 (delta) variant
por: Cai, Changjing, et al.
Publicado: (2021)

Coordinated Strategy for a Model-Based Decision Support Tool for Coronavirus Disease, Utah, USA
por: Meredith, Hannah R., et al.
Publicado: (2021)

Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern
por: Kondo, Taishi, et al.
Publicado: (2022)

Inequalities associated with emergence of Delta SARS-CoV-2 variant of concern (B.1.617.2) in England: awareness for future variants
por: Leeman, D., et al.
Publicado: (2022)

Will New Variants Emerge after Delta and Omicron?
por: Yang, Zhen, et al.
Publicado: (2022)

Neutralizing activity of BBIBP-CorV vaccine-elicited sera against Beta, Delta and other SARS-CoV-2 variants of concern
por: Yu, Xiaoqi, et al.
Publicado: (2022)

SARS-CoV-2 variants of concern Alpha and Delta show increased viral load in saliva
por: King, Kylie L., et al.
Publicado: (2022)

SARS-CoV-2 variants of concern Alpha and Delta show increased viral load in saliva
por: King, Kylie L., et al.
Publicado: (2022)

Omicron adopts a different strategy from Delta and other variants to adapt to host
por: Du, Xiaohong, et al.
Publicado: (2022)

Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern
por: Islam, Khursheed Ul, et al.
Publicado: (2021)

Comments on "Drinking water arsenic in Utah: a cohort mortality study".
por: Villanueva, C, et al.
Publicado: (1999)

Cautious Sexual Attitudes Diminish Intent to Vaccinate Children against HPV in Utah
por: Redd, David S., et al.
Publicado: (2022)

Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19
por: Linkins, Lori-Ann, et al.
Publicado: (2022)

Effect of vaccination on household transmission of SARS-CoV-2 Delta variant of concern
por: Lyngse, Frederik Plesner, et al.
Publicado: (2022)

Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the emergence of Delta variant of concern in Japan
por: Shoji, Kensuke, et al.
Publicado: (2022)

Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021
por: Thangaraj, Jeromie Wesley Vivian, et al.
Publicado: (2022)

Melatonin: Revisited Role as Vaccine Adjuvant During Outbreaks of COVID-19 Caused by the Delta Variant
por: Kow, Chia Siang, et al.
Publicado: (2021)

Human Rabies — Utah, 2018
por: Peterson, Dallin, et al.
Publicado: (2020)

Belief in vaccine myths and vaccine uptake in Utah during the COVID-19 pandemic
por: Omisakin, Olusola A., et al.
Publicado: (2023)

Investigation of vaccine breakthrough infections by vaccination scheme during the Delta variant wave in France
por: Bal, Antonin, et al.
Publicado: (2022)

COVID-19 Delta Variant-of-Concern: A Real Concern for Pregnant Women With Gestational Diabetes Mellitus
por: Mamun, Md Mahfuz Al, et al.
Publicado: (2021)

Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
por: Anft, Moritz, et al.
Publicado: (2022)

Evaluation of mortality risk after COVID-19 vaccination, Utah 2021
por: Payne, Jessica R., et al.
Publicado: (2023)

Intradermal versus intramuscular COVID-19 vaccination aiming at protection for delta variant: cost utility analysis
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

COVID-19 vaccines in the age of the delta variant
por: Wheatley, Adam K, et al.
Publicado: (2022)

Concerns regarding Covid-19 vaccine certificates
por: Spisak, Brian R., et al.
Publicado: (2021)

Comparative analysis of transmission and vaccine effectiveness in Omicron and Delta variant outbreaks in China
por: Li, Kangguo, et al.
Publicado: (2023)

Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2
por: Speer, Claudius, et al.
Publicado: (2021)

COVID-associated mucormycosis (CAM): is the Delta variant a cause?
por: Arakeri, Gururaj, et al.
Publicado: (2022)

Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns
por: Abassi, Leila, et al.
Publicado: (2023)

Emergence and Spread of the SARS-CoV-2 Variant of Concern Delta across Different Brazilian Regions
por: Arantes, Ighor, et al.
Publicado: (2022)

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
por: Lopez Bernal, Jamie, et al.
Publicado: (2021)

Comparative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Against the Delta Variant
por: Risk, Malcolm, et al.
Publicado: (2022)

SARS-CoV-2 Exposure in Escaped Mink, Utah, USA
por: Shriner, Susan A., et al.
Publicado: (2021)

Optimal Reopening Pathways With COVID-19 Vaccine Rollout and Emerging Variants of Concern
por: Xiao, Yanyu, et al.
Publicado: (2021)

Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern
por: Cohen-Dvashi, Hadas, et al.
Publicado: (2022)

A Utah flora.
Publicado: (1987)

The Utah neutrino detector
por: Keuffel, J W
Publicado: (1965)

Young people and COVID-19: emerging mental health concerns
por: Mughal, Faraz
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jkmhcirrafoum6i9piovjhaemf